Cowden
syndrome is part of the PTEN hamartoma tumor syndrome. Cowden syndrome is
characterized by a high risk of both benign and cancerous tumors of the breast,
thyroid, endometrium, colorectal, kidney, and skin. The global Cowden syndrome
market is expecting a healthy growth in the coming future. The global market is
majorly driven by increasing Cowden syndrome patients across the globe.
Additionally, increasing smoking population and rising consumption of alcohol
have spurred the growth of the market. However, long time for approval and side
effects of the treatment may hinder the growth of the market.
The
global Cowden syndrome market is expected to grow at a CAGR of 6.7% during the
forecast period 2017-2023.
Segmentation
The
global Cowden syndrome market is segmented on the basis of site, treatment and
end users.
On the
basis of the site, the market is segmented into the breast, thyroid,
endometrium (uterus), colorectal, kidney, skin (melanoma), and others.
On the
basis of the treatment, the market is categorized into genetic testing,
chemotherapy, surgery & radiation therapy, targeted therapy, hormone
therapy, biologic therapy, and other. The chemotherapy is further segmented
into anthracyclines, taxanes, antimetabolites, and alkylating agents. The
targeted therapy is sub-segmented with monoclonal antibodies and tyrosine
kinase inhibitors. Hormone therapy is further segmented into selective
estrogen-receptor modulators (SERMs), aromatase inhibitors, and others.
On the
basis of end users, the market is segmented into hospital & clinics,
ambulatory care centers, and others.
Regional
Analysis
The
Americas dominate the global Cowden syndrome market owing to the increasing
prevalence of people suffering from Cowden syndrome and cancer. Additionally,
high healthcare expenditure, well-developed technology, and strong government
support for research & development have fuelled the growth of the Americas
Cowden syndrome market. Presence of the leading players and increasing
availability of funds in this region are likely to support the growth in the
coming future.
Europe
accounts for the second largest Cowden syndrome market, which is followed by
the Asia Pacific. Availability of the funds for research & development and
strong government support have driven the market growth. The Asia Pacific is
the fastest growing Cowden syndrome market owing to the increasing prevalence
of cancer, rapidly developing the economy and increasing government support.
India and China are expected to lead the market in this region.
On the
other hand, the Middle East & Africa hold the least share of the market due
to limited availability of funds and availability of medical facilities, and
poor political conditions in Africa. The Middle East holds the major share in
the Middle East & Africa Cowden syndrome market. Kuwait, Qatar, Oman, and
South Arabia holds the major share of the Middle East market. However, the
African region is expecting a healthy growth due to the presence of a huge
opportunity for the development of the market.
Key
Players in Global Cowden Syndrome Market
Some of
key the players in the market are Novartis AG (Switzerland), GlaxoSmithKline
Plc. (U.K.), Bayer AG (Germany), Amgen, Inc. (U.S.), Eli Lilly and Company
(U.S.), AstraZeneca Plc. (U.K.), Bristol-Myers Squibb Company (U.S.), Sanofi
(France), AbbVie Inc. (U.S.), Spectrum Pharmaceuticals Inc. (U.S.), Takeda Pharmaceuticals
(Japan), Pfizer, Inc. (U.S.), Merck & Co., Inc. (U.S.), F. Hoffmann-La
Roche Ltd. (Switzerland), Janssen Biotech, Inc. (U.S.), Immunomedics (U.S.),
and Oncomed Pharmaceuticals (U.S.)
Detailed Table
of Contents for Cowden Syndrome Market
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6
Technology Trends & Assessment
About US:
Market
Research Future (MRFR), enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact
Us:
Market
Research Future
Office
No. 528, Amanora Chambers
Magarpatta
Road, Hadapsar,
Pune
- 411028
Maharashtra,
India
Phone:
+1 646 845 9312
No comments:
Post a Comment